Reproductive BioMedicine Online
Volume 19, Issue 6 , Pages 796-801, December 2009

Pronuclear zygote score following intracytoplasmic injection of hyaluronan-bound spermatozoa: a prospective randomized study

Received 6 January 2009; received in revised form 4 February 2009; accepted 10 August 2009. published online 02 August 2010.

Declaration: The authors report no financial or commercial conflicts of interest.

Abstract 

The aim of this study was to determine whether the early stages of embryo development, as assessed by the zygote score (Z-score), could be influenced by the injection of spermatozoa that had been preselected on the basis of their binding to hyaluronic acid (HA). A total of 407 sibling metaphase II oocytes, belonging to 44 different patients, were injected in a prospective randomized way, with either hyaluronic acid bound (HA+) or non-bound (HA) spermatozoa. The fertilization rate (75–70%), the percentage of the different Z-scores (Z1: 22–24%, Z2: 22–22.5%, Z3: 44–45%, Z4: 12–8.5%), the mean score of the transferred embryos (3.76±1.29, 3.78±1.1) and the number of embryos at the 4-cell stage 45h after injection (77–76%) were not different between the two groups. The ongoing pregnancy rate in this study (>20weeks of gestation) was 36.4% per replacement, the implantation rate 28% and the twin pregnancy rate 44% (7/16). Although binding to HA did not apparently influence the Z-score, this agent continues to be used for the immobilization of spermatozoa prior to injection, on the basis that it is a natural product that can easily be metabolized by the oocyte via normal biological mechanisms.

Keywords: hyaluronic acid, ICSI, nucleogenesis, Z-score, pronucleus

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Marc Van den Bergh graduated in 1977 in clinical chemistry from the Technical High School in Bruges, Belgium. He worked at the Centre for Reproductive Medicine at the Dutch-Speaking Free University of Brussels between 1979 and 1989. He co-ordinated the IVF-laboratory team at the Fertility Clinic of the French-Speaking Free University of Brussels between 1990 and 2001. In 2001 he obtained a special Master’s degree in clinical embryology at the Danube University of Krems, Austria. He obtained his certification as Senior Clinical Embryologist in 2008 and since 2002 he has directed the IVF laboratory at the Kantonsspital Baden AG, Switzerland.Marc Van den Bergh

PII: S1472-6483(09)00086-8

doi:10.1016/j.rbmo.2009.09.022

Reproductive BioMedicine Online
Volume 19, Issue 6 , Pages 796-801, December 2009